News
Media
Conferences
Blog
Publications
Partners
Resources
Subscribe
CE

|Videos|November 18, 2020

Overlapping diseases and COVID-19's impact

Author(s)Brooke Henson, Editor, Tracy Schroeder Swartz, OD, MS, FAAO, Marguerite McDonald, MD

Episodes in this series

EP. 1 Introduction and overview

EP. 1 Introduction and overview

EP. 2 Consequences and epidemiology of untreated dry eye

EP. 2 Consequences and epidemiology of untreated dry eye

EP. 3 Diagnosis and overlooking asymptomatic patients with DED

EP. 3 Diagnosis and overlooking asymptomatic patients with DED

EP. 4 Standard testing and assessment for DED

EP. 4 Standard testing and assessment for DED

EP. 5 General Principles of Treatment of DED

EP. 5 General Principles of Treatment of DED

EP. 6 OD and MD communication for optimal care

EP. 6 OD and MD communication for optimal care

EP. 7 Review of artificial tears for DED

EP. 7 Review of artificial tears for DED

EP. 8 Corticosteroids and Immunomodulators for the treatment of dry eye

EP. 8 Corticosteroids and Immunomodulators for the treatment of dry eye

Eric Donnenfeld, MD, and Marguerite McDonald, MD, discuss the role of nutritional supplements as well as antibiotics in dry eye management.

EP. 9 The role of nutritional supplements and antibiotics in DED

Crystal Brimer, OD, FAAO, identifies the preferred treatment options for meibomian gland dysfunction.

EP. 10 How to treat meibomian gland dysfunction

Crystal Brimer, OD, FAAO, shares some in-office procedures for dry eye and the patient resistance with high cost.

EP. 11 In-office procedures and patient resistance for DED treatments

EP. 12 Treatments for aqueous dry eye

EP. 12 Treatments for aqueous dry eye

EP. 13 Challenges in the management of DED

EP. 13 Challenges in the management of DED

EP. 14 Counseling and formulary concerns for DED therapies

EP. 14 Counseling and formulary concerns for DED therapies

EP. 15 Overlapping diseases and COVID-19's impact

EP. 15 Overlapping diseases and COVID-19's impact

EP. 16 Agents in the pipeline for DED

EP. 16 Agents in the pipeline for DED

EP. 17 Novel agents in the pipeline for DED

EP. 17 Novel agents in the pipeline for DED

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related Content

Julie McLaughlin, OD, DipABO

Simplifying the treatment of ocular surface disease

ByJulie McLaughlin, OD, DipABO

July 20th 2026

Esen K. Akpek, MD

Classifying dry eye by root cause: A step toward precision medicine

ByLucia Gambuzza,Esen K. Akpek, MD

July 17th 2026

Eye drop Image credit: AdobeStock

NMPA in China approves Heng Yi cyclosporine drop

ByOptometry Times Staff Reports

July 10th 2026

Mila Ioussifova, OD, CNS, FAAO, FOWNS

What to consider when treating patients with dry eye and menopause

ByMila Ioussifova, OD, FAAO,Jordana Joy, Editor

July 10th 2026

Ping Moore, OD

Understanding meibomian gland dysfunction, neuropathic pain, and the evolving dry eye patient

ByYun Ping Moore, OD,Lucia Gambuzza

July 9th 2026

Latest CME

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Solange Peters, MD, PhD; Benjamin P. Levy, MD; Tony S.K. Mok, MD, BMSc, FRCP(C), FRCP(Edin), FHKCP, FHKAM(Medicine), FASCO; Maurice Pérol, MD

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Solange Peters, MD, PhD; Stephanie McDonald, FNP-BC, AOCNP; Antonio Passaro, MD, PhD; Jacob Sands, MD

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

SriniVas Sadda, MD, FARVO; Nathan Steinle, MD

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Mark Schaeffer, OD, FAAO; Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO, FAAOMS; Selina R. McGee, OD, FAAO

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Simplifying the treatment of ocular surface disease

Classifying dry eye by root cause: A step toward precision medicine

3D-printed contact lenses offer patient-specific fit in 20 minutes

Atropine, aspherical lenses enter trial for childhood myopia

Lab-grown retinal cells restore vasculature in mouse studies